16/NOV
|
QUARTA |
|
| |
9:00 – 10:00 |
Welcome and Symposium Opening |
| |
10:00 -10:45 |
Animal Models of Pain: Are they translational models to develop novel therapies for pain? |
| |
10:45 – 11:30 |
Novel brain targets for the treatment of pain |
| |
11:30 – 12:15 |
Can neuroimaging, EEG and diagnostic TMS be used in the clinical practice of pain treatment? |
| |
12:15 – 13:30 |
Lunch break |
| |
13:30 – 15:00 |
Poster presentation |
| |
15:00 – 15:45 |
Disease modifying therapies for Parkinson’s disease |
| |
15:45 – 16:30 |
Diagnostic and disease progression biomarkers for Parkinson’s disease |
| |
16:30 – 17:15 |
Clinical trial methods to study novel neuroprotective strategies |
| |
17:15 – 18:00 |
Growth factors and neurotrophins to understand the mechanisms and treatmends of major depression |
| |
|
|
17/NOV
|
QUINTA |
|
| |
9:00 – 9:40 |
Neuroactive citokines as a treatment for mood disorders |
| |
9:40 – 10:20 |
The glutamatergic system as a critical pathway in the treatment of depression |
| |
10:20 – 11:00 |
Neurocircuitry-based novel targets for the treatment of depression |
| |
11:00 – 11:30 |
Brain and the gut microbiome: Paradigm Shift in Neurorehabilitation |
| |
11:30 – 12:15 |
Electrophysiological signatures and imaging biomarkers of autism |
| |
12:15 – 13:30 |
Lunch break |
| |
13:30 – 15:00 |
Poster presentation |
| |
15:00 – 15:45 |
Strategies and models for translational research in autism |
| |
15:45 – 16:30 |
Therapeutic development for autism |
| |
16:30 – 17:15 |
Catecholamines and the prefrontal cortex function in ADHD |
| |
17:15 – 18:00 |
Neurobiology of low-dose psychostimulants for ADHD |
| |
18:00 – 18:30 |
Non-pharmacological treatments for ADHD |
| |
|
|
18/NOV
|
SEXTA |
|
| |
9:00 – 9:30 |
Neuroimaging of learning |
| |
9:30 – 10:00 |
Research methods in Educational Neuroscience: deciding what to measure and a study design |
| |
10:00 – 10:45 |
Educating the mathematical brain |
| |
10:45 – 11:30 |
Development and application of scientific reasoning |
| |
11:30 – 12:15 |
Rehabilitation of touch and movement |
| |
12:15 – 13:30 |
Lunch break |
| |
13:30 – 15:00 |
Connectivity and language: understanding language deficits |
| |
15:00 – 15:45 |
Brain rythmns, sleep and our overall health |
| |
15:45 – 16:15 |
Neuroimaging of a creative and innovative mind |
| |
16:15 – 16:45 |
Presentation of Neuroscience Startup 1 |
| |
16:45 – 17:15 |
Presentation of Neuroscience Startup 2 |
| |
17:15 – 17:45 |
Presentation of Neuroscience Startup 3 |
| |
17:45 – 18:15 |
Presentation of Neuroscience Startup 4 |
| |
|
|
19/NOV
|
SÁBADO |
|
| |
8:00 – 10:30 |
Mini-symposium 1: The neuroscience of placebo effect and Its therapeutic effects |
| |
8:00 – 10:30 |
Mini-symposium 2: Understanding the impact of exercise as a therapeutic tool in neuroscience |
| |
10:30 – 13:00 |
Mini-simposium 3: A novel and non-invasive method to modulate the inflamatory system and brain plasticity: transcutaneous vagal nerve stimulation |
| |
10:30 – 13:00 |
Mini-simposium 4: The critical role of the prefrontal and frontal cortex |
| |
13:00 – 14:00 |
Lunch break |
| |
14:00 – 17:00 |
Mini-symposium 5: Basic principles and safety of transcranial direct current stimulation |
| |
14:00 – 17:00 |
Mini-symposium 6: The neuroscience of mindfullness and its use in rehabilitation |
| |
|
|
20/NOV
|
DOMINGO |
|
| |
8:00 – 10:30 |
Mini-symposium 7: Transcranial magnetic stimulation as a marker and treatment of neuropsychiatric disorders |
| |
8:00 – 10:30 |
Mini-symposium 8: Novel treatments for developmental disorders |
| |
10:30 – 13:00 |
Mini-simposium 9: Novel targets and neuroscience of aging |
| |
10:30 – 13:00 |
Mini-simposium 10: Transcranial focused ultrasound as a novel therapeutic tool in neurorehabilitation |
| |
13:00 – 14:00 |
Lunch break |
| |
14:00 – 17:00 |
Mini-symposium 11: Innovation in neuroscience: first steps to build your start-up |
| |
14:00 – 17:00 |
Mini-symposium 12: EEG and neurofeedback in neuroscience, neurorehabilitation and psychiatry |
| |
|
|
21/NOV
|
SEGUNDA |
|
| |
9:00 – 11:30 |
Mini-symposium 13: Neuroimaging in rehabilitation: fMRI and fNIRS |